GSK Vaccines, a world leader in vaccines based in Wavre, wins the biennial essenscia Innovation Award thanks to its candidate vaccine against shingles. The Innovation Award is the award for the most promising innovation in the Belgian chemical and life sciences sector. “It’s never easy to compare projects from such different domains, but the jury was unanimous on the choice of the winner,” says François Cornélis, jury chairman and former head of PetroFina and ToTal. “This is top Belgian research, which will create added value and more employment.”

BioVox
With a local focus and global reach, BioVox shares insights into the Belgian life sciences ecosystem with an ever-growing global community. BioVox is a non-profit project: we are able to provide our community with free, quality content because of the generous support of Turnstone Communications and its clients. Our articles bring you hidden opportunities and exclusive insights into the latest research and industry trends!
All posts